Trial Profile
A longitudinal computed tomography study of lenalidomide and bortezomib treatment in patients with multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Bortezomib
- Indications Multiple myeloma
- Focus Diagnostic use; Therapeutic Use
- 15 Dec 2015 New trial record